• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Helix BioMedix Inc

  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Programs
    • Pharma
    • Personal Care
  • News
    • Press Releases
    • Presentations
    • Scientific Publications
  • Investors
    • Stock Information
    • IR Updates
    • Proxy
    • Corporate Governance
  • Contact Page
You are here: Home / Archives for 2018

Archives for 2018

Peptide Library

Helix BioMedix, Inc. has created an extensive proprietary library of bioactive peptides based upon the diversity of structure, origin and activity of this class of innate immunity element.

Continue reading…

Filed Under: Category #1 Tagged With: Images Left, slider

Our Science

Helix BioMedix, Inc. has an extensive library of diverse bioactive peptides and patents covering a broad range of applications.

Continue reading…

Filed Under: Category #1 Tagged With: Images Left, slider

Programs

Helix BioMedix’s Drug Development Program focuses on unmet needs in the rare dermatological disease market.  Additionally, the Company has a long history of discovery and design of patented bioactive peptides for topical use in the personal care market.

Continue reading…

Filed Under: Category #1 Tagged With: Images Left, slider

Primary Sidebar

Footer

COMPANY PROFILE

Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum.  Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.

 

 

 

 

Terms & Conditions | Privacy Policy

Search

 

©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2025 · Executive Pro On Genesis Framework · WordPress · Log in